186 related articles for article (PubMed ID: 11350616)
21. Endometrioid adenocarcinoma arising from adenomyosis: a case report.
Szegedi S; Koppan M; Varga T; Kovacs K; Tinneberg HR; Bodis J
Eur J Gynaecol Oncol; 2016; 37(6):858-860. PubMed ID: 29943936
[TBL] [Abstract][Full Text] [Related]
22. [Endometrioid adenocarcinoma with proliferated stromal cells, hyalinization and cord-like formations: A case report].
Ning BH; Zhang QX; Yang H; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):366-369. PubMed ID: 37042152
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
Lin Z; Cho S; Jeong H; Kim H; Kim I
J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693
[TBL] [Abstract][Full Text] [Related]
24. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
Srodon M; Klein WM; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
[TBL] [Abstract][Full Text] [Related]
25. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
Fadare O; Parkash V
Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
[TBL] [Abstract][Full Text] [Related]
26. Endometrioid adenocarcinoma arising from endometriosis of the rectosigmoid.
Kobayashi S; Sasaki M; Goto T; Asakage N; Sekine M; Suzuki T; Tsukada K; Yamasaki S; Ukawa S
Dig Endosc; 2010 Jan; 22(1):59-63. PubMed ID: 20078668
[TBL] [Abstract][Full Text] [Related]
27. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis.
Mittal KR; Barwick KW
Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988
[TBL] [Abstract][Full Text] [Related]
28. Endometrioid adenocarcinoma arising in adenomyosis in a patient with pelvic organ prolapse-case report.
Wang J; Wang Q; Wang W; Yang J; Xia J; Wei Y
BMC Womens Health; 2023 Mar; 23(1):150. PubMed ID: 36997927
[TBL] [Abstract][Full Text] [Related]
29. Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Toyoda H; Hirai T; Ishii E
Pathol Int; 2000 Oct; 50(10):847-52. PubMed ID: 11107058
[TBL] [Abstract][Full Text] [Related]
30. Endometrioid adenocarcinoma arising from adenomyosis.
Takai N; Akizuki S; Nasu K; Etoh Y; Miyakawa I
Gynecol Obstet Invest; 1999; 48(2):141-4. PubMed ID: 10461008
[TBL] [Abstract][Full Text] [Related]
31. Adenomyosis and Endometrial Cancer: Literature Review.
Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
[TBL] [Abstract][Full Text] [Related]
32. Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.
Abushahin N; Zhang T; Chiang S; Zhang X; Hatch K; Zheng W
Int J Gynecol Pathol; 2011 May; 30(3):271-81. PubMed ID: 21464726
[TBL] [Abstract][Full Text] [Related]
33. Carcinosarcoma arising from uterine adenomyosis: A case report.
Kiuchi K; Hasegawa K; Kanamori A; Machida H; Kojima M; Fukasawa I
J Obstet Gynaecol Res; 2016 Mar; 42(3):358-62. PubMed ID: 26663238
[TBL] [Abstract][Full Text] [Related]
34. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Horiuchi A; Osada R; Nakayama K; Toki T; Nikaido T; Fujii S
Gynecol Oncol; 1998 Aug; 70(2):295-9. PubMed ID: 9740709
[TBL] [Abstract][Full Text] [Related]
35. Primary retroperitoneal Müllerian adenocarcinoma arising from endometriosis.
Tanaka K; Kobayashi Y; Shibuya H; Nishigaya Y; Momomura M; Matsumoto H; Iwashita M
J Obstet Gynaecol Res; 2014 Jun; 40(6):1823-7. PubMed ID: 24888958
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
37. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
38. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
39. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
40. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
